Discover 1,170 paid clinical trials in Montreal, Quebec. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,170
Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors
for
Breast Cancer, Non-small Cell Lung Cancer (NSCLC),
Location: Montreal, Omaha NE
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07660055
Phase1, Recruiting
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
for
Chronic Myelogenous Leukemia,
Location: Montreal, New York NY, New Brunswick NJ, Cincinnati OH,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 1 - 18
Code: NCT07354074
Phase2, Recruiting
A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction
for
Heart Failure With Reduced Ejection Fraction
Location: Montreal, Jacksonville FL, Winter Park FL, Inverness FL,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07465653
Phase1, Recruiting
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
for
Cardiovascular Disease and Lipoprotein(a)
Location: Montreal, Quebec, Lebanon NH, Scarborough ME, Boston MA,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07517263
Phase3, Recruiting
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
for
Somatostatin Receptor Positive (SSTR+),
Location: Montreal, Hartford CT, New Haven CT, New York NY,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 12 - 70+
Code: NCT06784752
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.